Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

PATHXLAB

UiPath Inc.

PATH · $14.13

65Good

Exascale Labs Holdings Inc.

XLAB · $3.35

76Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

PATH

65/100

XLAB

76/100

Quality

Is it a profitable, well-run business?

PATH

5.3/10

XLAB

n/a

Growth

Is the company growing?

PATH

6.5/10

XLAB

n/a

Valuation

Is the price reasonable? (higher = cheaper)

PATH

8.0/10

XLAB

n/a

Risk

How risky are the shares? (higher = lower risk)

PATH

4.3/10

XLAB

4.2/10

Momentum

Is the share price trending up?

PATH

8.2/10

XLAB

7.6/10

Financial strength

Is the balance sheet healthy?

PATH

8.5/10

XLAB

n/a

The balanced view

Model-generated

UiPath Inc.

This company scores above average, with a healthy balance sheet and a positive price trend, although analysts are cautious.

Leads on: quality, growth, valuation, risk, momentum, financial strength

Best feature: healthy balance sheet (Debt / Equity: 0.04)

Watch out: analysts are cautious (Analyst buy share: 21%)

Exascale Labs Holdings Inc.

There isn't enough financial data to give this stock a reliable overall score.

Leads on: no single area

Best feature: positive price trend (RSI (14): 57.2)

Watch out: shares can be volatile (Largest 1Y drawdown: -85%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.